Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2022-08-11 00:00:00 ET · period of report 2022-08-10 · accession 0001171843-22-005617 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-11 | 2022-08-10 | ANIK | Levitz Michael L | EVP, CFO, Treas | M - OptEx | $0.00 | +3,859 | 20.4K | +23% | $0 |
| D | 2022-08-11 | 2022-08-10 | ANIK | Levitz Michael L | EVP, CFO, Treas | M - OptEx | $0.00 | -3,859 | 3,859 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-10 | M | A | 3,859 | $0.00 | 20,423 | D | — | — | (F1) Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020. The 3,859 shares resulting from the RSU vest were retained in full as a result of Mr. Levitz's election to pay cash to cover the applicable taxes resulting from the RSU vest. (F2) Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022. |
| 2 | Derivative | Restricted Stock Unit | 2022-08-10 | M | D | 3,859 | $0.00 | 3,859 | D | $0.00 · — to — | 3,859 Common Stock | (F3) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021. |